Chengdu Easton Biopharmaceuticals (688513.SH) announced on June 3 that as of the end of May 2024, the company had repurchased a total of 1,091,092 shares of the company through centralized bidding trading, accounting for 0.9086% of the total share capital. The highest purchase price was 56.05 yuan/share, the lowest purchase price was 43.5 yuan/share, and the total transaction amount was RMB 54,282,923.09 (excluding stamp duty, transaction fees, and other trading expenses).
苑东生物(688513.SH)：已累计回购0.9086%公司股份
Chengdu Easton Biopharmaceuticals (688513.SH): has repurchased 0.9086% of the company's shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.